This article was written by Follow ONeil Trader is a former stockbroker turned full-time independent investor. He focuses on finding growth and biotech stocks...
This article was written by Follow Excellent academic Finance background and Finance professional with over five years of cumulative experience in Consulting & Audit...
By Jeffrey Schulze, CFA, Investment Strategist, ClearBridge Investments In this episode, we speak with Jeff Schulze, head of economic and market research at ClearBridge...
Investment Summary Following a series of investment updates since my April publication on Avanos Medical, Inc. (NYSE:AVNS), there is still the potential to unlock...
Introduction Invitae (NYSE:NVTA) is a leading provider of genetic testing services, digital health solutions, and health data services. Their genetic tests cover various clinical...